Brevan Howard Capital Management LP Haemonetics Corp Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Haemonetics Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 24,642 shares of HAE stock, worth $1.82 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,642
Previous 24,810
0.68%
Holding current value
$1.82 Million
Previous $1.94 Million
19.2%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding HAE
# of Institutions
351Shares Held
53.3MCall Options Held
417KPut Options Held
314K-
Black Rock Inc. New York, NY5.96MShares$440 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$376 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$321 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$194 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$162 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.79B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...